Mecamylamine hydrochloride - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for mecamylamine hydrochloride and what is the scope of patent protection?

Mecamylamine hydrochloride is the generic ingredient in two branded drugs marketed by Targacept and Lgm Pharma, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for mecamylamine hydrochloride. Two suppliers are listed for this compound.

Summary for mecamylamine hydrochloride

US Patents:	0
Tradenames:	2
Applicants:	2
NDAs:	2
Drug Master File Entries:	2
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	80
Clinical Trials:	31
Patent Applications:	740
What excipients (inactive ingredients) are in mecamylamine hydrochloride?	mecamylamine hydrochloride excipients list
DailyMed Link:	mecamylamine hydrochloride at DailyMed

Recent Clinical Trials for mecamylamine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Vanderbilt University Medical Center	Early Phase 1
Wayne State University	Phase 4
AstraZeneca	Phase 2

See all mecamylamine hydrochloride clinical trials

Pharmacology for mecamylamine hydrochloride

Drug Class	Autonomic Ganglionic Blocker
Physiological Effect	Decreased Autonomic Ganglionic Activity

Medical Subject Heading (MeSH) Categories for mecamylamine hydrochloride

Antihypertensive Agents
Ganglionic Blockers
Nicotinic Antagonists

Anatomical Therapeutic Chemical (ATC) Classes for mecamylamine hydrochloride

C02BB	Secondary and tertiary amines
C02B	ANTIADRENERGIC AGENTS, GANGLION-BLOCKING
C02	ANTIHYPERTENSIVES
C	Cardiovascular system

US Patents and Regulatory Information for mecamylamine hydrochloride

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lgm Pharma	MECAMYLAMINE HYDROCHLORIDE	mecamylamine hydrochloride	TABLET;ORAL	204054-001	Mar 19, 2013		RX	No	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Targacept	INVERSINE	mecamylamine hydrochloride	TABLET;ORAL	010251-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.